ROLE OF CYCLIN D1 IN THE MECHANISMS OF TAMOXIFEN RESISTANCE
Hormone-receptor positive breast cancer is the most common molecular subtype and represents 60–75 % of all breast cancers (BC). The presence of specific molecular targets such as the estrogen/progesterone receptor determines the use of hormone therapy for patients with this subtype. Tamoxifen, a sel...
Saved in:
Main Authors: | D. B. Erdyneeva, N. N. Babyshkina, T. A. Dronova, S. V. Vtorushin, E. M. Slonimskaya, V. N. Stegniy, N. V. Cherdyntseva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2020-09-01
|
Series: | Сибирский онкологический журнал |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/1540 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CHANGES IN DNA METHYLATION PROFILE IN TAMOXIFEN-RESISTANT MCF-7 SUBLINES
by: О. Е. Andreeva, et al.
Published: (2019-11-01) -
Features of ovarian steroidogenesis and endometrial hypertrophy during adjuvant therapy with tamoxifen in premenopausal patients with hormone-dependent breast cancer
by: A. Yu. Goryainova, et al.
Published: (2023-05-01) -
ROLE OF MORPHOLOGICAL AND GENETIC STRUCTURAL CHARACTERISTICS OF ESTROGEN RECEPTOR ALPHA IN THE DEVELOPMENT OF RESISTANCE TO ENDOCRINOTHERAPY WITH TAMOXIFEN IN PATIENTS WITH LUMINAL BREAST CANCER
by: Е. М. Slonimskaya, et al.
Published: (2016-02-01) -
Integration of phosphoinositide 3-kinase (PI3K) and transforming growth factor β1 (TGF-β1) signaling cascades: role in the therapeutic inefficiency of tamoxifen
by: N. N. Babyshkina, et al.
Published: (2023-12-01) -
Prognostic Value of Cyclin D1 Overexpression in Invasive Breast Carcinoma
by: Funda Taşlı, et al.
Published: (2025-04-01)